Cargando…
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer
An in-house enzyme-linked immunosorbent assay (ELISA) was developed in this study to detect circulating IgG antibodies to peptide antigens derived from baculoviral IAP repeat-containing protein 5 isoform 2 (BIRC5) and myc proto-oncogene protein (MYC) in non-small cell lung cancer (NSCLC). Student’s...
Autores principales: | Ye, Leiguang, Wang, Weili, Chen, Cairen, Meng, Qingyong, Yu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600849/ https://www.ncbi.nlm.nih.gov/pubmed/26566475 http://dx.doi.org/10.1016/j.fob.2015.09.007 |
Ejemplares similares
-
Further study of circulating IgG antibodies to CD25‐derived peptide antigens in nonsmall cell lung cancer
por: Chen, Cairen, et al.
Publicado: (2016) -
Study of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer
por: Xu, Yangchun, et al.
Publicado: (2015) -
Plasma anti‐BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer
por: Zhao, Huan, et al.
Publicado: (2018) -
Circulating IgG antibodies to periodontal bacteria and lung cancer risk in the CLUE cohorts
por: Ampomah, Nana K, et al.
Publicado: (2023) -
Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)